PT  - JOURNAL ARTICLE
AU  - Bupathi, Manojkumar
AU  - Wang, Judy S
AU  - Hu-Lieskovan, Siwen
AU  - Piha-Paul, Sarina A
AU  - Chmielowski, Bartosz
AU  - Garmezy, Benjamin
AU  - Najjar, Yana G
AU  - Stein, Mark N
AU  - Yao, Li
AU  - Kanodia, Jitendra
AU  - Clynes, Raphael
AU  - McGovern, Patricia
AU  - Thompson, Benjamin
TI  - 764 A phase 1, first-in-human (FIH), open-label, dose-finding and expansion study of XmAb808, a B7H3 x CD28 bispecific antibody, in combination with pembrolizumab in patients with advanced solid tumors
AID  - 10.1136/jitc-2023-SITC2023.0764
DP  - 2023 Nov 01
TA  - Journal for ImmunoTherapy of Cancer
PG  - A859--A859
VI  - 11
IP  - Suppl 1
4099  - http://jitc.bmj.com/content/11/Suppl_1/A859.short
4100  - http://jitc.bmj.com/content/11/Suppl_1/A859.full
SO  - J Immunother Cancer2023 Nov 01; 11
AB  - Markup server — Error Not Found The page you were trying to reach could not be found. Please check the address for the page you were trying to reach. If you believe you have reached this page in error, you may contact us with any questions.